It doesn't take 2 months to analyse data when it's an unblinded trial, where results can be monitored constantly. Could be announced almost immediately.
Any gap will be to alter trial protocol to max trial outcomes.
"according to data from the London Stock Exchange, of the 22 British companies that have listed in New York over the last decade, on average the share price has dropped by 38pc. Indeed, only three, including Manchester United, are above the IPO price."
AS said a while ago that he certainly expected the results in humans to be better than in mice due to a lower background concentration of FAP in the non tumour environment of humans.